Avelumab

3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Avelumab
Treatment and conditionWhere it standsTrials
Avelumab for carcinoma, transitional cellPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Avelumab for endometrial neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Avelumab for gliomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1